Loading…
The change of antizyme inhibitor expression and its possible role during mammalian cell cycle
Antizyme inhibitor (AIn), a homolog of ODC, binds to antizyme and inactivates it. We report here that AIn increased at the G1 phase of the cell cycle, preceding the peak of ODC activity in HTC cells in culture. During interphase AIn was present mainly in the cytoplasm and turned over rapidly with th...
Saved in:
Published in: | Experimental cell research 2009-08, Vol.315 (13), p.2301-2311 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c415t-8d861a7d5417edd5d57fd0cccc0d1e5aba852fb94ba2bf5c00f555f617f7db9c3 |
---|---|
cites | cdi_FETCH-LOGICAL-c415t-8d861a7d5417edd5d57fd0cccc0d1e5aba852fb94ba2bf5c00f555f617f7db9c3 |
container_end_page | 2311 |
container_issue | 13 |
container_start_page | 2301 |
container_title | Experimental cell research |
container_volume | 315 |
creator | Murakami, Yasuko Suzuki, Jun-ichiro Samejima, Keijiro Kikuchi, Kenjiro Hascilowicz, Tomasz Murai, Noriyuki Matsufuji, Senya Oka, Takami |
description | Antizyme inhibitor (AIn), a homolog of ODC, binds to antizyme and inactivates it. We report here that AIn increased at the G1 phase of the cell cycle, preceding the peak of ODC activity in HTC cells in culture. During interphase AIn was present mainly in the cytoplasm and turned over rapidly with the half-life of 10 to 20 min, while antizyme was localized in the nucleus. The level of AIn increased again at the G2/M phase along with ODC, and the rate of turn-over of AIn in mitotic cells decreased with the half-life of approximately 40 min. AIn was colocalized with antizyme at centrosomes during the period from prophase through late anaphase and at the midzone/midbody during telophase. Thereafter, AIn and antizyme were separated and present at different regions on the midbody at late telophase. AIn disappeared at late cytokinesis, whereas antizyme remained at the cytokinesis remnant. Reduction of AIn by RNA interference caused the increase in the number of binucleated cells in HTC cells in culture. These findings suggested that AIn contributed to a rapid increase in ODC at the G1 phase and also played a role in facilitating cells to complete mitosis during the cell cycle. |
doi_str_mv | 10.1016/j.yexcr.2009.04.024 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67371098</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0014482709001955</els_id><sourcerecordid>20070115</sourcerecordid><originalsourceid>FETCH-LOGICAL-c415t-8d861a7d5417edd5d57fd0cccc0d1e5aba852fb94ba2bf5c00f555f617f7db9c3</originalsourceid><addsrcrecordid>eNqFkcFrFDEUxoModm39CwQJHrzN9CWbTDIHD1KsCoVe6rGETPKmm2UmsyYzpetfb7a7IHjQHBJCfu_Le99HyDsGNQPWXG7rPT65VHOAtgZRAxcvyIpBCxUXnL8kKwAmKqG5OiNvct4CgNaseU3OWCt4o7hekfu7DVK3sfEB6dRTG-fwaz8iDXETujBPieLTLmHOYYrl1dMwZ7qbyr0bkKapbH5JIT7Q0Y6jHYKN1OEwULd3A16QV70dMr49nefkx_WXu6tv1c3t1-9Xn28qJ5icK-11w6zyUjCF3ksvVe_BlQWeobSd1ZL3XSs6y7teOoBeStk3TPXKd61bn5OPR91dmn4umGczhnxow0aclmwatVbFGP1fsHipgDFZwA9_gdtpSbEMYYp5jZa6XRdofYRcKo4k7M0uhdGmvWFgDhmZrXnO6KDbGhCmZFSq3p-kl25E_6fmFEoBPh0BLJY9Bkwmu4DRoQ8J3Wz8FP75wW_ImKT-</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>194685893</pqid></control><display><type>article</type><title>The change of antizyme inhibitor expression and its possible role during mammalian cell cycle</title><source>ScienceDirect Freedom Collection</source><creator>Murakami, Yasuko ; Suzuki, Jun-ichiro ; Samejima, Keijiro ; Kikuchi, Kenjiro ; Hascilowicz, Tomasz ; Murai, Noriyuki ; Matsufuji, Senya ; Oka, Takami</creator><creatorcontrib>Murakami, Yasuko ; Suzuki, Jun-ichiro ; Samejima, Keijiro ; Kikuchi, Kenjiro ; Hascilowicz, Tomasz ; Murai, Noriyuki ; Matsufuji, Senya ; Oka, Takami</creatorcontrib><description>Antizyme inhibitor (AIn), a homolog of ODC, binds to antizyme and inactivates it. We report here that AIn increased at the G1 phase of the cell cycle, preceding the peak of ODC activity in HTC cells in culture. During interphase AIn was present mainly in the cytoplasm and turned over rapidly with the half-life of 10 to 20 min, while antizyme was localized in the nucleus. The level of AIn increased again at the G2/M phase along with ODC, and the rate of turn-over of AIn in mitotic cells decreased with the half-life of approximately 40 min. AIn was colocalized with antizyme at centrosomes during the period from prophase through late anaphase and at the midzone/midbody during telophase. Thereafter, AIn and antizyme were separated and present at different regions on the midbody at late telophase. AIn disappeared at late cytokinesis, whereas antizyme remained at the cytokinesis remnant. Reduction of AIn by RNA interference caused the increase in the number of binucleated cells in HTC cells in culture. These findings suggested that AIn contributed to a rapid increase in ODC at the G1 phase and also played a role in facilitating cells to complete mitosis during the cell cycle.</description><identifier>ISSN: 0014-4827</identifier><identifier>EISSN: 1090-2422</identifier><identifier>DOI: 10.1016/j.yexcr.2009.04.024</identifier><identifier>PMID: 19426728</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Animals ; Antineoplastic Agents - pharmacology ; Antizyme ; Antizyme inhibitor ; Carrier Proteins - genetics ; Carrier Proteins - metabolism ; Cell culture ; Cell cycle ; Cell Cycle - drug effects ; Cell Cycle - physiology ; Cell division ; Cell Line, Tumor ; Cell-Free System ; Centrosome ; Cytokinesis ; Eflornithine - metabolism ; Enzyme Stability ; Inhibitor drugs ; Mammals ; Nocodazole - pharmacology ; ODC ; Ornithine Decarboxylase - metabolism ; Ornithine Decarboxylase Inhibitors ; Polyamines - metabolism ; Proteins - metabolism ; Rats ; RNA, Messenger - metabolism ; RNA, Small Interfering - genetics ; RNA, Small Interfering - metabolism</subject><ispartof>Experimental cell research, 2009-08, Vol.315 (13), p.2301-2311</ispartof><rights>2009 Elsevier Inc.</rights><rights>Copyright © 2009 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c415t-8d861a7d5417edd5d57fd0cccc0d1e5aba852fb94ba2bf5c00f555f617f7db9c3</citedby><cites>FETCH-LOGICAL-c415t-8d861a7d5417edd5d57fd0cccc0d1e5aba852fb94ba2bf5c00f555f617f7db9c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19426728$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Murakami, Yasuko</creatorcontrib><creatorcontrib>Suzuki, Jun-ichiro</creatorcontrib><creatorcontrib>Samejima, Keijiro</creatorcontrib><creatorcontrib>Kikuchi, Kenjiro</creatorcontrib><creatorcontrib>Hascilowicz, Tomasz</creatorcontrib><creatorcontrib>Murai, Noriyuki</creatorcontrib><creatorcontrib>Matsufuji, Senya</creatorcontrib><creatorcontrib>Oka, Takami</creatorcontrib><title>The change of antizyme inhibitor expression and its possible role during mammalian cell cycle</title><title>Experimental cell research</title><addtitle>Exp Cell Res</addtitle><description>Antizyme inhibitor (AIn), a homolog of ODC, binds to antizyme and inactivates it. We report here that AIn increased at the G1 phase of the cell cycle, preceding the peak of ODC activity in HTC cells in culture. During interphase AIn was present mainly in the cytoplasm and turned over rapidly with the half-life of 10 to 20 min, while antizyme was localized in the nucleus. The level of AIn increased again at the G2/M phase along with ODC, and the rate of turn-over of AIn in mitotic cells decreased with the half-life of approximately 40 min. AIn was colocalized with antizyme at centrosomes during the period from prophase through late anaphase and at the midzone/midbody during telophase. Thereafter, AIn and antizyme were separated and present at different regions on the midbody at late telophase. AIn disappeared at late cytokinesis, whereas antizyme remained at the cytokinesis remnant. Reduction of AIn by RNA interference caused the increase in the number of binucleated cells in HTC cells in culture. These findings suggested that AIn contributed to a rapid increase in ODC at the G1 phase and also played a role in facilitating cells to complete mitosis during the cell cycle.</description><subject>Animals</subject><subject>Antineoplastic Agents - pharmacology</subject><subject>Antizyme</subject><subject>Antizyme inhibitor</subject><subject>Carrier Proteins - genetics</subject><subject>Carrier Proteins - metabolism</subject><subject>Cell culture</subject><subject>Cell cycle</subject><subject>Cell Cycle - drug effects</subject><subject>Cell Cycle - physiology</subject><subject>Cell division</subject><subject>Cell Line, Tumor</subject><subject>Cell-Free System</subject><subject>Centrosome</subject><subject>Cytokinesis</subject><subject>Eflornithine - metabolism</subject><subject>Enzyme Stability</subject><subject>Inhibitor drugs</subject><subject>Mammals</subject><subject>Nocodazole - pharmacology</subject><subject>ODC</subject><subject>Ornithine Decarboxylase - metabolism</subject><subject>Ornithine Decarboxylase Inhibitors</subject><subject>Polyamines - metabolism</subject><subject>Proteins - metabolism</subject><subject>Rats</subject><subject>RNA, Messenger - metabolism</subject><subject>RNA, Small Interfering - genetics</subject><subject>RNA, Small Interfering - metabolism</subject><issn>0014-4827</issn><issn>1090-2422</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><recordid>eNqFkcFrFDEUxoModm39CwQJHrzN9CWbTDIHD1KsCoVe6rGETPKmm2UmsyYzpetfb7a7IHjQHBJCfu_Le99HyDsGNQPWXG7rPT65VHOAtgZRAxcvyIpBCxUXnL8kKwAmKqG5OiNvct4CgNaseU3OWCt4o7hekfu7DVK3sfEB6dRTG-fwaz8iDXETujBPieLTLmHOYYrl1dMwZ7qbyr0bkKapbH5JIT7Q0Y6jHYKN1OEwULd3A16QV70dMr49nefkx_WXu6tv1c3t1-9Xn28qJ5icK-11w6zyUjCF3ksvVe_BlQWeobSd1ZL3XSs6y7teOoBeStk3TPXKd61bn5OPR91dmn4umGczhnxow0aclmwatVbFGP1fsHipgDFZwA9_gdtpSbEMYYp5jZa6XRdofYRcKo4k7M0uhdGmvWFgDhmZrXnO6KDbGhCmZFSq3p-kl25E_6fmFEoBPh0BLJY9Bkwmu4DRoQ8J3Wz8FP75wW_ImKT-</recordid><startdate>20090801</startdate><enddate>20090801</enddate><creator>Murakami, Yasuko</creator><creator>Suzuki, Jun-ichiro</creator><creator>Samejima, Keijiro</creator><creator>Kikuchi, Kenjiro</creator><creator>Hascilowicz, Tomasz</creator><creator>Murai, Noriyuki</creator><creator>Matsufuji, Senya</creator><creator>Oka, Takami</creator><general>Elsevier Inc</general><general>Elsevier BV</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7TM</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope></search><sort><creationdate>20090801</creationdate><title>The change of antizyme inhibitor expression and its possible role during mammalian cell cycle</title><author>Murakami, Yasuko ; Suzuki, Jun-ichiro ; Samejima, Keijiro ; Kikuchi, Kenjiro ; Hascilowicz, Tomasz ; Murai, Noriyuki ; Matsufuji, Senya ; Oka, Takami</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c415t-8d861a7d5417edd5d57fd0cccc0d1e5aba852fb94ba2bf5c00f555f617f7db9c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Animals</topic><topic>Antineoplastic Agents - pharmacology</topic><topic>Antizyme</topic><topic>Antizyme inhibitor</topic><topic>Carrier Proteins - genetics</topic><topic>Carrier Proteins - metabolism</topic><topic>Cell culture</topic><topic>Cell cycle</topic><topic>Cell Cycle - drug effects</topic><topic>Cell Cycle - physiology</topic><topic>Cell division</topic><topic>Cell Line, Tumor</topic><topic>Cell-Free System</topic><topic>Centrosome</topic><topic>Cytokinesis</topic><topic>Eflornithine - metabolism</topic><topic>Enzyme Stability</topic><topic>Inhibitor drugs</topic><topic>Mammals</topic><topic>Nocodazole - pharmacology</topic><topic>ODC</topic><topic>Ornithine Decarboxylase - metabolism</topic><topic>Ornithine Decarboxylase Inhibitors</topic><topic>Polyamines - metabolism</topic><topic>Proteins - metabolism</topic><topic>Rats</topic><topic>RNA, Messenger - metabolism</topic><topic>RNA, Small Interfering - genetics</topic><topic>RNA, Small Interfering - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Murakami, Yasuko</creatorcontrib><creatorcontrib>Suzuki, Jun-ichiro</creatorcontrib><creatorcontrib>Samejima, Keijiro</creatorcontrib><creatorcontrib>Kikuchi, Kenjiro</creatorcontrib><creatorcontrib>Hascilowicz, Tomasz</creatorcontrib><creatorcontrib>Murai, Noriyuki</creatorcontrib><creatorcontrib>Matsufuji, Senya</creatorcontrib><creatorcontrib>Oka, Takami</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Experimental cell research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Murakami, Yasuko</au><au>Suzuki, Jun-ichiro</au><au>Samejima, Keijiro</au><au>Kikuchi, Kenjiro</au><au>Hascilowicz, Tomasz</au><au>Murai, Noriyuki</au><au>Matsufuji, Senya</au><au>Oka, Takami</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The change of antizyme inhibitor expression and its possible role during mammalian cell cycle</atitle><jtitle>Experimental cell research</jtitle><addtitle>Exp Cell Res</addtitle><date>2009-08-01</date><risdate>2009</risdate><volume>315</volume><issue>13</issue><spage>2301</spage><epage>2311</epage><pages>2301-2311</pages><issn>0014-4827</issn><eissn>1090-2422</eissn><abstract>Antizyme inhibitor (AIn), a homolog of ODC, binds to antizyme and inactivates it. We report here that AIn increased at the G1 phase of the cell cycle, preceding the peak of ODC activity in HTC cells in culture. During interphase AIn was present mainly in the cytoplasm and turned over rapidly with the half-life of 10 to 20 min, while antizyme was localized in the nucleus. The level of AIn increased again at the G2/M phase along with ODC, and the rate of turn-over of AIn in mitotic cells decreased with the half-life of approximately 40 min. AIn was colocalized with antizyme at centrosomes during the period from prophase through late anaphase and at the midzone/midbody during telophase. Thereafter, AIn and antizyme were separated and present at different regions on the midbody at late telophase. AIn disappeared at late cytokinesis, whereas antizyme remained at the cytokinesis remnant. Reduction of AIn by RNA interference caused the increase in the number of binucleated cells in HTC cells in culture. These findings suggested that AIn contributed to a rapid increase in ODC at the G1 phase and also played a role in facilitating cells to complete mitosis during the cell cycle.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>19426728</pmid><doi>10.1016/j.yexcr.2009.04.024</doi><tpages>11</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0014-4827 |
ispartof | Experimental cell research, 2009-08, Vol.315 (13), p.2301-2311 |
issn | 0014-4827 1090-2422 |
language | eng |
recordid | cdi_proquest_miscellaneous_67371098 |
source | ScienceDirect Freedom Collection |
subjects | Animals Antineoplastic Agents - pharmacology Antizyme Antizyme inhibitor Carrier Proteins - genetics Carrier Proteins - metabolism Cell culture Cell cycle Cell Cycle - drug effects Cell Cycle - physiology Cell division Cell Line, Tumor Cell-Free System Centrosome Cytokinesis Eflornithine - metabolism Enzyme Stability Inhibitor drugs Mammals Nocodazole - pharmacology ODC Ornithine Decarboxylase - metabolism Ornithine Decarboxylase Inhibitors Polyamines - metabolism Proteins - metabolism Rats RNA, Messenger - metabolism RNA, Small Interfering - genetics RNA, Small Interfering - metabolism |
title | The change of antizyme inhibitor expression and its possible role during mammalian cell cycle |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T13%3A08%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20change%20of%20antizyme%20inhibitor%20expression%20and%20its%20possible%20role%20during%20mammalian%20cell%20cycle&rft.jtitle=Experimental%20cell%20research&rft.au=Murakami,%20Yasuko&rft.date=2009-08-01&rft.volume=315&rft.issue=13&rft.spage=2301&rft.epage=2311&rft.pages=2301-2311&rft.issn=0014-4827&rft.eissn=1090-2422&rft_id=info:doi/10.1016/j.yexcr.2009.04.024&rft_dat=%3Cproquest_cross%3E20070115%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c415t-8d861a7d5417edd5d57fd0cccc0d1e5aba852fb94ba2bf5c00f555f617f7db9c3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=194685893&rft_id=info:pmid/19426728&rfr_iscdi=true |